CVE:SBM Sirona Biochem (SBM) Stock Forecast, Price & News C$0.10 -0.01 (-9.52%) (As of 10:30 AM ET) Add Compare Share Share Today's RangeC$0.10▼C$0.1050-Day RangeC$0.10▼C$0.1252-Week RangeC$0.08▼C$0.22Volume600 shsAverage Volume60,827 shsMarket CapitalizationC$23.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesProfileChartCompetitorsHeadlines About Sirona Biochem (CVE:SBM) StockSirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.Read More SBM Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBM Stock News HeadlinesSeptember 23, 2023 | americanbankingnews.comSirona Biochem (CVE:SBM) Stock Price Up 4.8%August 22, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp up on Monday (SBM)September 26, 2023 | Micro-Cap Stock Trader (Ad)Unlock the treasure on Mount Olympus with this little-known mining stock.Investor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsJune 28, 2023 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEBJune 28, 2023 | finance.yahoo.comSirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEBMay 25, 2023 | stockhouse.comSirona Biochem Engages Atheln Inc. to Strengthen Business Development InitiativesMay 11, 2023 | finance.yahoo.comSirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-GodefroyMay 10, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp down on Tuesday (SBM)September 26, 2023 | Micro-Cap Stock Trader (Ad)Unlock the treasure on Mount Olympus with this little-known mining stock.Investor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsMay 6, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp down on Wednesday (SBM)May 4, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp up on Wednesday (SBM)May 3, 2023 | finance.yahoo.comSirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in BostonMay 2, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp down on Monday (SBM)April 25, 2023 | finance.yahoo.comSirona Biochem Announces Exceptional Clinical Trial Results for Anti-Aging Compound TFC-1326April 25, 2023 | proactiveinvestors.comSirona Biochem stock climbs on anti-aging compound clinical trial resultsApril 22, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp up on Friday (SBM)April 21, 2023 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Announces Close of Oversubscribed Debenture FinancingApril 20, 2023 | finance.yahoo.comSirona Biochem Announces Close of Oversubscribed Debenture FinancingApril 13, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp flat on Wednesday (SBM)April 8, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp flat on Thursday (SBM)March 23, 2023 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Announces Debenture FinancingMarch 23, 2023 | finance.yahoo.comSirona Biochem Announces Debenture FinancingMarch 19, 2023 | benzinga.comEnzo Biochem shares are trading higher after the company announced it will sell its clinical laboratory to Labcorp.March 1, 2023 | finance.yahoo.comSirona Biochem Receives Antiviral Testing ResultsFebruary 6, 2023 | technews.tmcnet.comWilliam R. Brody, MD, PhD joins Sirona Medical's Board of Directors to help accelerate radiology's IT transformation.January 16, 2023 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Announces the Termination of Supply Agreement with Rodan + FieldsDecember 31, 2022 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Announces 2022 Annual Meeting ResultsSee More Headlines Receive SBM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:SBM CUSIPN/A CIKN/A Webwww.sironabiochem.com Phone604-641-4466FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-2,130,000.00 Net Margins-291.37% Pretax MarginN/A Return on Equity-9,810.47% Return on Assets-72.54% Debt Debt-to-Equity Ratio219.21 Current Ratio2.05 Quick Ratio2.41 Sales & Book Value Annual SalesC$683,768.00 Price / Sales35.03 Cash FlowC$0.00 per share Price / Cash Flow35.00 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares252,110,000Free FloatN/AMarket CapC$23.95 million OptionableNot Optionable Beta-0.27 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Howard J. Verrico M.D. (Age 62)Ph.D., Founder, Chairman, CEO & Sec. Comp: $161.28kMr. Christopher D. Hopton C.G.A. (Age 57)C.P.A., CFO & Director Comp: $147.84kDr. Géraldine Deliencourt-Godefroy Ph.D.Chief Scientific Officer & DirectorKey CompetitorsMedicenna TherapeuticsTSE:MDNAAcasti PharmaCVE:ACSTAntibe TherapeuticsTSE:ATECeaproCVE:CZOIBEX TechnologiesCVE:IBTView All Competitors SBM Stock - Frequently Asked Questions How have SBM shares performed in 2023? Sirona Biochem's stock was trading at C$0.12 at the start of the year. Since then, SBM stock has decreased by 17.4% and is now trading at C$0.10. View the best growth stocks for 2023 here. What other stocks do shareholders of Sirona Biochem own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP). What is Sirona Biochem's stock symbol? Sirona Biochem trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SBM." How do I buy shares of Sirona Biochem? Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Sirona Biochem's stock price today? One share of SBM stock can currently be purchased for approximately C$0.10. How much money does Sirona Biochem make? Sirona Biochem (CVE:SBM) has a market capitalization of C$23.95 million and generates C$683,768.00 in revenue each year. The company earns C$-2,130,000.00 in net income (profit) each year or C($0.01) on an earnings per share basis. How can I contact Sirona Biochem? Sirona Biochem's mailing address is 595 Burrard Street, Vancouver, BC V7X 1L4, Canada, . The official website for the company is www.sironabiochem.com. The company can be reached via phone at 604-641-4466. This page (CVE:SBM) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sirona Biochem Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.